Biotech firm Septerna on Thursday said it raised $288 million in its initial public offering that has been upsized twice, a sign of upbeat investor sentiment for the capital-intensive sector.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
